LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal

Zacks12-17

Labcorp Holdings, Inc. LH has entered into an agreement with MAWD Pathology Group in Lenexa, KS, to acquire select assets of its clinical and women’s health testing businesses. Both companies share a ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2492952976?lang=en_US&edition=fundamental","thumbnail":"https://s.yimg.com/uu/api/res/1.2/x7AJ0AkRL_CYuqXFyPb2BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5","is_english":true,"pubTime":"2024-12-17 20:03","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2492952976","market":"us","top_or_hot":-1,"title":"LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal","media":"Zacks","content":"<div>\n<p>Labcorp Holdings, Inc. LH has entered into an agreement with MAWD Pathology Group in Lenexa, KS, to acquire select assets of its clinical and women’s health testing businesses. Both companies share a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lh-stock-may-gain-select-120300575.html\">Source Link</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>LH Stock May Gain From Select MAWD Pathology Asset Purchase Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLH Stock May Gain From Select MAWD Pathology Asset Purchase Deal\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-17 20:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/lh-stock-may-gain-select-120300575.html><strong>Zacks</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Labcorp Holdings, Inc. LH has entered into an agreement with MAWD Pathology Group in Lenexa, KS, to acquire select assets of its clinical and women’s health testing businesses. Both companies share a ...</p>\n\n<a href=\"https://finance.yahoo.com/news/lh-stock-may-gain-select-120300575.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0006061336.USD","symbol_name":"Blackrock US Small and MidCap Opportunities A2 USD","start_time":0,"source_url":"https://finance.yahoo.com/news/lh-stock-may-gain-select-120300575.html","article_id":"2492952976","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/x7AJ0AkRL_CYuqXFyPb2BQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/c8704ffaba0234da981fa842a48f77b5"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492952976","pubTimestamp":1734436980,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"Labcorp Holdings, Inc. LH has entered into an agreement with MAWD Pathology Group in Lenexa, KS, to acquire select assets of its clinical and women’s health testing businesses. Both companies share a commitment to improving community health through high-quality laboratory services.The transaction is anticipated to close in early 2025, subject to customary closing conditions. In the meantime, operations or services will remain unchanged.Following the announcement yesterday, Labcorp shares dipped by nearly 1%, finishing at $229.62. On a promising note, the company’s extensive pipeline of potential hospital and local laboratory acquisitions presents significant opportunities for its growth. Labcorp continues to execute its strategic priorities well by being a partner of choice for health systems and regional local laboratories, leveraging science and innovation to expand leadership in important therapeutic areas and utilizing data and technology to bring important services and capabilitie","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD","PEN":"Penumbra Inc","BK4548":"巴美列捷福持仓","LU0205193047.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD)  ACC","PAHC":"Phibro Animal Health Corporation","LU0205194284.USD":"SCHRODER ISF US SMALL & MID-CAP EQUITY \"A\" (USD) INC AV","BK4585":"ETF&股票定投概念","SLCT":"Select Bancorp Inc.","LH":"徕博科","BK4007":"制药","BK4196":"保健护理服务","LU1169590202.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"I\" (USD) ACC","LU1169589451.USD":"ALLSPRING (LUX)  U.S. SELECT EQUITY \"A\" (USD) ACC","LU0106261612.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" ACC","IE00BLDYK493.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) INC","BK4082":"医疗保健设备","BK4588":"碎股","BK4550":"红杉资本持仓","BK4198":"医疗保健用品","LU0012050646.USD":"SCHRODER ISF US SMALLER COMPANIES IMPACT \"A\" (USD) INC AV","HAE":"美国血液技术","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC"},"translate_title":"LH股票可能会从部分MAWD病理学资产购买交易中受益","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LH":1,"SLCT":1,"PEN":1,"PAHC":1,"HAE":0.9},"content_text":"Labcorp Holdings, Inc. LH has entered into an agreement with MAWD Pathology Group in Lenexa, KS, to acquire select assets of its clinical and women’s health testing businesses. Both companies share a commitment to improving community health through high-quality laboratory services.\nThe transaction is anticipated to close in early 2025, subject to customary closing conditions.  In the meantime, operations or services will remain unchanged.\nLH Stock’s Likely Trend Following the News\nFollowing the announcement yesterday, Labcorp shares dipped by nearly 1%, finishing at $229.62. On a promising note, the company’s extensive pipeline of potential hospital and local laboratory acquisitions presents significant opportunities for its growth. Labcorp continues to execute its strategic priorities well by being a partner of choice for health systems and regional local laboratories, leveraging science and innovation to expand leadership in important therapeutic areas and utilizing data and technology to bring important services and capabilities to the customers. Henceforth, we expect the market sentiment toward the LH stock to remain positive surrounding this news.\nLabcorp has a market capitalization of $19.41 billion. Going by the Zacks Consensus Estimate, the company’s earnings are expected to grow by 7.1% on a 0.7% improvement in revenues. It surpassed earnings estimates in each of the trailing four quarters, with an average beat of 2.87%. \nMore on LH’s New Acquisition\nUpon completion, the transaction is expected to provide patients, physicians and customers with greater access to Labcorp’s high-quality laboratory services and expanded testing capabilities in communities across Kansas City and the surrounding region. MAWD Pathology Group will continue to provide comprehensive anatomic professional and technical pathology and related services. Labcorp is focused on building MAWD Pathology’s long tradition of high-quality laboratory and healthcare services.\nImage Source: Zacks Investment Research\nMeanwhile, this latest development follows other acquisitions and strategic relationships that Labcorp has finalized with a range of local and regional health systems and laboratories that have enhanced services for patients and providers.\nIndustry Prospects Favoring LH\nPer a research report, the global clinical laboratory services market was at $233.24 billion in 2023 and is expected to grow at a compound annual rate of 3.5% through 2030. The market growth is driven by factors such as the increasing burden of chronic diseases and the growing demand for early diagnostic tests. Moreover, rapid advancements in data management and sample preparation due to growing volumes of testing samples are anticipated to boost market growth during the forecast period.\nLabcorp’s Recent Developments\nLast week, Labcorp announced it has finalized its acquisition of select outreach laboratory services from Ballad Health. The acquisition aims to enhance access to comprehensive, high-quality laboratory services for communities in the Appalachian region. Also, in November 2024, Labcorp acquired select assets and the molecular testing location of Lab Works, an accredited independent clinical laboratory located in Birmingham, AL.\nLH Stock Price Performance\nIn the past six months, Labcorp shares have rallied 11.3% compared with the industry’s 0.5% rise.\nLH’s Zacks Rank and Top MedTech Stocks\nLabcorp currently carries a Zacks Rank #3 (Hold).\nSome better-ranked stocks in the broader medical space are Penumbra PEN, Haemonetics HAE and Phibro Animal Health PAHC, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.\nPenumbra shares have dropped 0.1% in the past year. Estimates for the company’s 2024 earnings per share have increased 2 cents to $2.81 in the past 30 days. PEN’s earnings beat estimates in three of the trailing four quarters and missed on one occasion, the average surprise being 10.54%. In the last reported quarter, it posted an earnings surprise of 23.19%.\nEstimates for Haemonetics’ fiscal 2025 earnings per share have remained constant at $4.59 in the past 30 days. Shares of the company have dropped 7% in the past year against the industry’s growth of 13.9%. HAE’s earnings surpassed estimates in three of the trailing four quarters and missed in one, the average surprise being 2.82%. In the last reported quarter, it delivered an earnings surprise of 2.75%.\nEstimates for Phibro Animal Health’s fiscal 2025 earnings per share have increased 1.9% to $1.62 in the past 30 days. Shares of the company have surged 100% in the past year compared with the industry’s 13.9% rise. PAHC’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 25.47%. In the last reported quarter, it delivered an earnings surprise of 52.17%.\nWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report\nLabcorp (LH) : Free Stock Analysis Report\nHaemonetics Corporation (HAE) : Free Stock Analysis Report\nPhibro Animal Health Corporation (PAHC) : Free Stock Analysis Report\nPenumbra, Inc. (PEN) : Free Stock Analysis Report\nTo read this article on Zacks.com click here.\nZacks Investment Research","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492952976"}